Dr. Jang has over 30 years of experience in the pharmaceutical industry. Prior to forming BRIM, she worked at Sterling Winthrop (Kodak), Sanofi, DuPont, and Centocor (J&J). She was Senior Director of Biologics Clinical Pharmacology at Centocor.
Dr. Lee was formerly the VP of DMPK at Millennium Pharmaceuticals (Takeda). He has over 41 years of experience in global pharmaceutical companies, with expertise in preclinical DMPK, toxicity assessment, and clinical trial strategy.
Top Taiwan Venture Capital Group
Top Taiwan Venture Capital Group (“TTVC”) is the largest and leading venture capital management team based in Taiwan with a fund size around $400 million
BioEngine Capital, Inc.
BioEngine Capital Inc. is an evergreen fund and is the venture capital arm of Center Laboratories, a listed Taiwanese pharmaceutical company